Potential conflict of interest: Dr. Lee consults for and received grants from Merck. He received grants from Anadys, Boehringer Ingelheim, Bristol-Myers Squibb, Vertex, Ocera, and Gilead.
Liver Failure/Cirrhosis/Portal Hypertension
Steroid use in acute liver failure
Version of Record online: 24 DEC 2013
© 2013 by the American Association for the Study of Liver Diseases
Volume 59, Issue 2, pages 612–621, February 2014
How to Cite
Karkhanis, J., Verna, E. C., Chang, M. S., Stravitz, R. T., Schilsky, M., Lee, W. M., Brown, R. S. and for the Acute Liver Failure Study Group (2014), Steroid use in acute liver failure. Hepatology, 59: 612–621. doi: 10.1002/hep.26678
- Issue online: 29 JAN 2014
- Version of Record online: 24 DEC 2013
- Accepted manuscript online: 8 AUG 2013 08:28AM EST
- Manuscript Accepted: 27 JUL 2013
- Manuscript Received: 25 FEB 2013
Additional Supporting Information may be found in the online version of this article.
|hep26678-sup-0001-supptable1.docx||37K||Supporting Table 1: Quartiles of AST, ALT and MELD|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.